Preskoči na vsebino

Kardiotorakalna in vaskularna kirurgija (pediatrija)

Management and Optimization of Hemostasis

Antifibrinolytic Agents

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (odpre novo okno)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Vir‎: Anesth Analg 2006;102(3):731-7.

Indeksirano‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (odpre novo okno)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (odpre novo okno)

Basta MN, Stricker PA, Taylor JA.

Vir‎: Pediatr Surg Int 2012;28(11):1059-69.

Indeksirano‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (odpre novo okno)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (odpre novo okno)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Vir‎: Br J Anaesth 2012;108(5):830-7.

Indeksirano‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (odpre novo okno)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (odpre novo okno)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Vir‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Indeksirano‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (odpre novo okno)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (odpre novo okno)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Vir‎: Ann Thorac Surg 2000;70(4):1308-12.

Indeksirano‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (odpre novo okno)

The Bayer 022 compassionate-use pediatric study. (odpre novo okno)

Coniff RF.

Vir‎: Ann Thorac Surg 1998;65(6 Suppl):S31-3.

Indeksirano‎: PubMed 9647135

https://www.ncbi.nlm.nih.gov/pubmed/9647135 (odpre novo okno)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (odpre novo okno)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Vir‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indeksirano‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (odpre novo okno)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (odpre novo okno)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Vir‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Indeksirano‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (odpre novo okno)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (odpre novo okno)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Vir‎: PLoS One 2015;10(5):e0126514.

Indeksirano‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (odpre novo okno)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (odpre novo okno)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Vir‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indeksirano‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (odpre novo okno)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (odpre novo okno)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Vir‎: Br J Anaesth 2013;110(4):615-21.

Indeksirano‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (odpre novo okno)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (odpre novo okno)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Vir‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indeksirano‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (odpre novo okno)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (odpre novo okno)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Vir‎: Ann Card Anaesth 2015;18(1):23-6.

Indeksirano‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (odpre novo okno)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (odpre novo okno)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Vir‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indeksirano‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (odpre novo okno)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (odpre novo okno)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Vir‎: Eur J Anaesthesiol 2015;32(12):844-50.

Indeksirano‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (odpre novo okno)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (odpre novo okno)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Vir‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Indeksirano‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (odpre novo okno)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (odpre novo okno)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Vir‎: Ann Card Anaesth 2010;13(2):110-5.

Indeksirano‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (odpre novo okno)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (odpre novo okno)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Vir‎: Anesthesiology 2015;122(4):746-58.

Indeksirano‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (odpre novo okno)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (odpre novo okno)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Vir‎: Ann Thorac Surg 2011;92(3):958-63.

Indeksirano‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (odpre novo okno)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (odpre novo okno)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Vir‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Indeksirano‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (odpre novo okno)

Recombinant Activated Factor VII (rFVIIa)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (odpre novo okno)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Vir‎: Ann Thorac Surg 2007;84(1):161-8.

Indeksirano‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (odpre novo okno)

Pediatric off-label use of recombinant factor VIIa. (odpre novo okno)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Vir‎: Pediatrics 2009;123(3):1066-72.

Indeksirano‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (odpre novo okno)

Factor VII for excessive bleeding following congenital heart disease surgery. (odpre novo okno)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Vir‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Indeksirano‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (odpre novo okno)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (odpre novo okno)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Vir‎: Paediatr Anaesth 2009;19(4):364-70.

Indeksirano‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (odpre novo okno)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (odpre novo okno)

Guzzetta NA, Russell IA, Williams GD.

Vir‎: Anesth Analg 2012;115(2):364-78.

Indeksirano‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (odpre novo okno)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (odpre novo okno)

Okonta KE, Edwin F, Falase B.

Vir‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Indeksirano‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (odpre novo okno)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (odpre novo okno)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Vir‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indeksirano‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (odpre novo okno)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (odpre novo okno)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Vir‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indeksirano‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (odpre novo okno)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (odpre novo okno)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Vir‎: J Clin Anesth 2014;26(3):204-11.

Indeksirano‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (odpre novo okno)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (odpre novo okno)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Vir‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indeksirano‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (odpre novo okno)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (odpre novo okno)

Tobias JD, Berkenbosch JW, Russo P.

Vir‎: Pediatr Crit Care Med 2003;4(1):49-51.

Indeksirano‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (odpre novo okno)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (odpre novo okno)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Vir‎: J Intensive Care Med 2004;19(5):270-3.

Indeksirano‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (odpre novo okno)

Recombinant activated factor VII in cardiac surgery: a systematic review. (odpre novo okno)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Vir‎: Ann Thorac Surg 2007;83(2):707-14.

Indeksirano‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (odpre novo okno)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (odpre novo okno)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Vir‎: Pediatr Crit Care Med 2009;10(5):572-82.

Indeksirano‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (odpre novo okno)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (odpre novo okno)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Vir‎: Pediatr Cardiol 2013;34(1):119-24.

Indeksirano‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (odpre novo okno)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (odpre novo okno)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Vir‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indeksirano‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (odpre novo okno)

Coagulation Factor Concentrates

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (odpre novo okno)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Vir‎: Artif Organs 2010;34(11):955-60.

Indeksirano‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (odpre novo okno)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (odpre novo okno)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Vir‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indeksirano‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (odpre novo okno)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (odpre novo okno)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Vir‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Indeksirano‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (odpre novo okno)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (odpre novo okno)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Vir‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indeksirano‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (odpre novo okno)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (odpre novo okno)

Noga T, Bruce AA, Blain H, Nahirniak S.

Vir‎: Vox Sang 2016;110(3):253-7.

Indeksirano‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (odpre novo okno)

Topical Hemostatic Agents

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (odpre novo okno)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Vir‎: Ann Surg 2010;251(2):217-28.

Indeksirano‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (odpre novo okno)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (odpre novo okno)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Vir‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Indeksirano‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (odpre novo okno)

Viscoelastic Tests to Identify Surgical or Coagulopathic Bleeding

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (odpre novo okno)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Vir‎: Ann Card Anaesth 2012;15(1):26-31.

Indeksirano‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (odpre novo okno)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (odpre novo okno)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Vir‎: Artif Organs 2010;34(11):955-60.

Indeksirano‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (odpre novo okno)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (odpre novo okno)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Vir‎: Br J Anaesth 2015;114(1):91-102.

Indeksirano‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (odpre novo okno)

KARDIOTORAKALNA IN VASKULARNA KIRURGIJA (PEDIATRIJA)
Management and Optimization of Hemostasis
slovenščina
Management and Optimization of Hemostasis
https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Odbori za stike z bolnišnicami (OSB)

Kontaktirajte z lokalnim predstavnikom, ki je brezplačno na voljo zdravnikom, ki zdravijo Jehovove priče.

Kontakt

Paketi informacij za zdravnike

Teme so med drugim: klinični pristopi za preprečevanje in obvladovanje krvavitve in anemije brez transfuzije krvi; verski in etični pogled Jehovovih prič na zdravljenje; storitve, ki jih Jehovove priče nudijo zdravstvenemu osebju po svoji svetovni mreži odborov za stike z bolnišnicami.

Ogled gradiva

Videoposnetki

Zdravnikom, ki zdravijo Jehovove priče, so predstavljene možnosti zdravljenja ter medicinski in etični vidiki.

Ogled videoposnetkov